Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Dec 6;5(23):5116–5127. doi: 10.1182/bloodadvances.2021004827

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

PMC Copyright notice

Figure 4. — Targeting MADD to mitochondria displaces Rab27A from WPBs. HUVECs were transduced with TOMM70-EGFP (A) or TOMM70-EGFP-MADD (B) or TOMM70-EGFP-MADD-ΔDENN (C) (all shown in green) and immunostained for VWF (blue), Rab27A (red), and VE cadherin (not shown). Boxed areas are magnified on the right. Yellow arrowheads indicate Rab27A⁺and cyan arrowheads indicate Rab27A^– WPBs. Scale bars represent 10 µm. (D) Quantification of the percentage of transduced (GFP⁺) HUVECs containing Rab27A⁺ WPBs in TOMM70-EGFP (175 cells analyzed), TOMM70-EGFP-MADD (96 cells analyzed), and TOMM70-EGFP-MADD-ΔDENN (38 cells analyzed). Data are shown as mean and were analyzed by using one-way ANOVA with Dunnet’s multiple comparisons test. *P < .05.